Evidence map›Paper›PMID 20159237›Full record

ReviewThe Journal of allergy and clinical immunology2010

The role of pharmacogenomics in improving the management of asthma.

Shamsah Kazani, Michael E Wechsler, Elliot Israel

Registry-linked trialAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02360696 (Predictors of Clinical Response to Montelukast in Children With Functional Dyspepsia), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02360696 completednot on this mapstarted 2014, after this paper: background citation

Predictors of Clinical Response to Montelukast in Children With Functional Dyspepsia

TypeobservationalSponsorChildren's Mercy Hospital Kansas CityRan2014 to 2016Enrolled18ConditionsEosinophilia, Dyspepsia
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Mechanisms and therapeutic strategies of asthma: from bench to bedside.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Prototype of a Standards-Based EHR and Genetic Test Reporting Tool Coupled with HL7-Compliant Infobuttons.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2018
    Article
  6. Article
  7. Pharmacogenetics of Asthma.Indian journal of pediatrics · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Advancing asthma care: the glass is only half full!The Journal of allergy and clinical immunology · 2011
    Review
  12. Advances in pediatric asthma in 2010: addressing the major issues.The Journal of allergy and clinical immunology · 2011
    Review
  13. Article
  14. Article
  15. Beta-Adrenergic Agonists.Pharmaceuticals (Basel, Switzerland) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shamsah KazaniPulmonary and Critical Care Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Michael E Wechsler
Elliot Israel

Funding

Informative Clinical Studies in AsthmaU10HL074227 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ISRAEL, ELLIOT · 2003 to 2007
$5.8M
NHLBI NIH HHS U10 HL074227NHLBI NIH HHS U10 HL74227
6 · The paper itself

Abstract

There is a large amount of interindividual variability in both therapeutic and adverse responses to asthma therapies. Genetic variability can account for 50% to 60% of this variability. Pharmacogenomics holds out the promise of allowing clinicians to prospectively choose therapies that have the greatest likelihood to be effective for individual patients and to avoid those that might have a high likelihood of producing adverse effects. In this article we review the principles of pharmacogenomic investigation. We explore the data developed from the early pharmacogenomic studies with the most common asthma therapies. Furthermore, we explore the potential use of pharmacogenomics, as well as caveats in interpreting such information.

Indexed as

Anti-Asthmatic AgentsAsthmaHumansPharmacogeneticsAnti-Asthmatic Agents

Identifiers

PMID20159237
PMCPMC2824610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.